What is the recommended medical management for endometriosis?

Medical Management of Endometriosis

For pain relief in endometriosis, start with oral contraceptives or progestogens (including depot medroxyprogesterone acetate) as first-line therapy, as they are equally effective to more costly regimens and offer the best balance of efficacy, tolerability, and cost. 1

First-Line Medical Therapy

The evidence-based approach prioritizes hormonal suppression to control symptoms:

• Combined oral contraceptives (COCs) or progestogens (oral or depot medroxyprogesterone acetate) are recommended as initial therapy based on Level B evidence 1
• These agents are effective compared to placebo and may be equivalent to more expensive regimens 1
• 52mg levonorgestrel-releasing intrauterine system (LNG-IUS) is also recommended as first-line treatment 2
• NSAIDs can be added for symptomatic pain relief 1, 3

Key Point: All these medications reduce lesion size but do not eradicate endometriosis, and there is no evidence they improve future fertility 1

Second-Line Medical Therapy

When first-line agents fail to control symptoms:

• GnRH agonists for at least 3 months are equally effective to danazol for 6 months (Level A evidence) 1
• Add-back therapy (estrogen/progestin) must be used with GnRH agonists to prevent bone mineral loss without reducing pain relief efficacy 1
• Oral GnRH antagonists (such as relugolix combination therapy) offer promising long-term pain control 4, 5
• Dienogest (19-nortestosterone derivative) improves endometriosis-related symptoms and quality of life 3
• Aromatase inhibitors serve as second-line agents for refractory pain 3

Treatment Without Surgical Confirmation

GnRH agonist therapy is appropriate for chronic pelvic pain even without laparoscopic confirmation of endometriosis, provided initial evaluation excludes other causes (Level B evidence) 1. This is particularly relevant for adolescents where avoiding surgery is preferred 6.

Disease Severity Considerations

• Severe endometriosis: Medical treatment alone may be insufficient; consider surgical intervention (Level C evidence) 1
• Asymptomatic patients: Expectant management is appropriate since endometriosis can be unpredictable and may regress 1
• Multiorgan involvement or treatment failure: Requires multidisciplinary team evaluation 2

Critical Caveats

Important limitations to understand:

1. No medical therapy eradicates endometriosis lesions - all treatments are suppressive 1
2. Medical therapy does not improve fertility - antigonadotrophic hormonal therapy is not recommended for infertility management 1, 2
3. Surgical recurrence is common - up to 44% experience symptom recurrence within one year post-surgery 1
4. Pain severity does not correlate with lesion appearance but does correlate with lesion depth 1

Post-Surgical Management

After surgical treatment when pregnancy is not desired:

• COCs or 52mg LNG-IUS are recommended first-line to prevent recurrence 2
• Hormone replacement therapy is not contraindicated after hysterectomy with bilateral salpingo-oophorectomy for endometriosis 1

Practical Algorithm

1. Start: COCs, progestogens, or LNG-IUS + NSAIDs
2. If inadequate response: Switch to alternative first-line agent or add GnRH agonist/antagonist with add-back therapy
3. If still refractory: Consider dienogest, aromatase inhibitors, or surgical consultation
4. Severe disease or multiorgan involvement: Early multidisciplinary evaluation and likely surgical intervention

The goal is continuous suppressive therapy to control symptoms and slow disease progression, recognizing that this is a chronic condition requiring long-term management 4, 5.